Logo Contact Us

10-Year Heart Risk Assessment – A Proactive Approach to Cardiovascular Care

In the world of preventive healthcare, early detection is everything. And when it comes to cardiovascular disease, one of the most effective tools available today is the 10-year heart risk assessment. This simple yet powerful metric allows healthcare providers to estimate a patient’s likelihood of developing heart disease over the next decade, enabling timely intervention and long-term planning.

What Is a 10-Year Heart Risk Assessment?

A 10-year heart risk assessment is a calculation that considers a variety of risk factors including age, gender, cholesterol levels, blood pressure, smoking status, diabetes, and more. The result is a percentage score that represents the individual’s risk of experiencing a heart event, such as a heart attack or stroke, within 10 years.

This information helps clinicians:

  • Stratify patients by risk level
  • Prioritize interventions like lifestyle changes or medication
  • Educate patients about their personal cardiovascular risk

Why This Matters for Pharma Brand Managers

For pharmaceutical brands in cardiology, this risk tool provides a unique entry point to introduce therapies aligned with risk levels. The better informed the patient is about their risk, the more likely they are to accept and adhere to prescribed treatment.

Where SYNQOL Health Screen Comes In

SYNQOL Health Screen by Indigital Technologies brings this predictive tool to life in a clinical setting. While patients wait, they can engage with:

  • Interactive risk assessments designed to evaluate 10-year heart risk
  • Educational videos explaining what heart risk scores mean
  • Lifestyle content tailored to heart health, diet, and activity

These features not only inform but also prime patients for meaningful conversations with their doctor.

Smart Clinics Run on Proactive Data

When a patient completes a heart risk assessment on SYNQOL while waiting, the results are instantly visible to the doctor. This means:

  • No time wasted during the consultation
  • Immediate insight into the patient’s risk level
  • Better alignment between patient awareness and doctor action

Enhanced Patient Buy-In

Patients are more likely to agree to therapy when they understand their risk. SYNQOL makes risk personal, visual, and understandable. And for the pharma sector, this translates to:

  • Higher uptake of cardiovascular medications
  • Improved compliance with long-term regimens
  • Brand visibility in the context of prevention and education

The Value Proposition

For clinics aiming to implement cardiovascular risk stratification, and for pharma brands supporting cardiovascular care, SYNQOL is the missing link between data, education, and decision-making.

It turns the passive waiting period into an active screening moment. It informs. It engages. It prepares both doctor and patient for what matters most: prevention.

With SYNQOL Health Screen, every minute in the waiting room becomes a step toward a healthier heart.